Myeloma Crowd Radio/MCRI: Dr. Hermann Einsele, MD and Dr. Michael Hudecek, MD

CAR T cell therapy is a new and exciting potential treatment approach in blood cancers. It is a highly personalized treatment because the patient's own T-cells are redirected to erradicate cancerous cells after a single infusion, allowing patients to avoid the chronic side effects of long-term, toxic chemoradiotherapy. Learn more about Dr. Hermann Einsele, MD and Dr. Michael Huedecek, MD's work at the University of  Würzburg, Germany to use a CAR T cell therapy targeting the CS1 protein commonly found on myeloma cells.